Hydrochloric Acid

Hydrochloric Acid

SCHEMBL19405604

[Cl-].[Mg+2].[O-][Si](c1ccccc1F)(c1ccccc1F)c1ccccc1F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.35
NFE2L2 Q16236 1/20 0.33
DCUN1D1 Q96GG9 1/20 0.31
NISCH Q9Y2I1 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PKM P14618 1/20 0.31
RAB9A P51151 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TAAR1 Q96RJ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL19405493 0.95 ACHE (0.35) ACHENFE2L2DCUN1D1CES2CES1
Hydrochloric Acid SCHEMBL19405474 0.81 CES2 (0.35) CES2CES1
Hydrochloric Acid SCHEMBL19405531 0.81 ACHE (0.37) ACHENFE2L2NPC1RAB9A
Hydrochloric Acid SCHEMBL19583281 0.81 ACHE (0.37) ACHENFE2L2NISCHNPC1ALDH1A1
Bromide SCHEMBL19405535 0.76 ACHE (0.37) ACHENFE2L2NPC1RAB9A
Bromide SCHEMBL19405691 0.76 CES2 (0.35) CES2CES1
Bromide SCHEMBL19405463 0.76 ACHE (0.37) ACHENFE2L2NPC1ALDH1A1PKM
Hydrochloric Acid SCHEMBL19405427 0.71 ALDH1A1 (0.39) NFE2L2CES2CES1NPC1ALDH1A1
SCHEMBL2574473 0.70 CES2 (0.40) ACHENFE2L2DCUN1D1CES2CES1
Hydrochloric Acid SCHEMBL19405536 0.70 TSHR (0.43) ACHENISCHNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10367231-B2 Magnesium-containing electrolytic solution FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-07-30 US disclosed
EP-3226340-B1 MAGNESIUM-CONTAINING ELECTROLYTIC SOLUTION FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2018-11-07 EP disclosed
US-20170331154-A1 MAGNESIUM-CONTAINING ELECTROLYTIC SOLUTION WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2017-11-16 US disclosed
EP-3226340-A1 MAGNESIUM-CONTAINING ELECTROLYTIC SOLUTION Wako Pure Chemical Industries, Ltd. (JP) 2017-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10367231-B2 Magnesium-containing electrolytic solution CA1, CA3, CA2 ACHE 188/4885NFE2L2 639/4885DCUN1D1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.